对RNA疫苗进行非临床安全测试
1The NCD Company, Polling, Germany. mail@gundel-hager.de.
Methods in molecular biology (Clifton, N.J.)
|May 30, 2024
概括
本章概述了用于药物开发的非临床安全测试,重点关注RNA疫苗安全要求和样本测试计划. 它涵盖了监管背景和基本的毒性测试需求.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 疫苗开发 疫苗开发
- 监管科学 监管科学
背景情况:
- 非临床安全测试对于药物开发至关重要.
- 了解监管环境对于合规至关重要.
- 对于RNA疫苗等新型模式的具体考虑正在出现.
研究的目的:
- 定义药物开发中非临床安全测试的目标.
- 为管理安全测试的监管框架提供概述.
- 详细说明RNA疫苗的安全测试要求,并提出一个样本计划.
主要方法:
- 审查监管指南和科学文献.
- 对一般安全性/毒性测试原则的分析.
- 开发一个RNA疫苗安全性评估框架.
主要成果:
- 确定了非临床安全评估的基本目标.
- 总结了药物安全测试的关键监管要求.
- 概述了针对RNA疫苗量身定制的特定安全测试策略.
结论:
- 非临床安全测试是药物开发的关键,受监管的组成部分.
- RNA疫苗需要量身定制的安全测试方法.
- 结构化的安全测试计划对于确保基于RNA的疗法安全至关重要.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K


